Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT12 | Individual Protein | Human immunodeficiency virus type 1 integrase | Human immunodeficiency virus 1 | IC50 | = | 7300 | nM | 18954075 |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 28183.8 | nM | 22850207 |
NPT533 | Protein-Protein Interaction | Runt-related transcription factor 1/Core-binding factor subunit beta | Homo sapiens | Potency | 11220.2 | nM | 14738383 | |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 8912.5 | nM | 23713692 |
NPT533 | Protein-Protein Interaction | Runt-related transcription factor 1/Core-binding factor subunit beta | Homo sapiens | Potency | 28183.8 | nM | 17158937 | |
NPT151 | Individual Protein | 15-hydroxyprostaglandin dehydrogenase [NAD+] | Homo sapiens | Potency | = | 1412.5 | nM | 20733039 |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 39810.7 | nM | 20020916 |
NPT199 | Individual Protein | DNA polymerase kappa | Homo sapiens | Potency | 3548.1 | nM | 17685651 | |
NPT12 | Individual Protein | Human immunodeficiency virus type 1 integrase | Human immunodeficiency virus 1 | IC50 | = | 4600 | nM | 15730245 |
NPT12 | Individual Protein | Human immunodeficiency virus type 1 integrase | Human immunodeficiency virus 1 | Inhibition | = | 89.7 | % | 18672931 |
NPT12 | Individual Protein | Human immunodeficiency virus type 1 integrase | Human immunodeficiency virus 1 | IC50 | = | 4900 | nM | 18672931 |
NPT24 | Organism | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | ED50 | = | 8.4 | nM | 17958396 |
NPT23 | Individual Protein | Integrase | Human immunodeficiency virus 1 | IC50 | = | 4900 | nM | 17958396 |
NPT23 | Individual Protein | Integrase | Human immunodeficiency virus 1 | IC50 | = | 4600 | nM | 17958396 |
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | 56234.1 | nM | 15270579 | |
NPT443 | Individual Protein | Histone acetyltransferase GCN5 | Homo sapiens | Potency | 19952.6 | nM | 24467317 | |
NPT12 | Individual Protein | Human immunodeficiency virus type 1 integrase | Human immunodeficiency virus 1 | Inhibition | = | 94.4 | % | 10.6019/CHEMBL1201861 |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 4466.8 | nM | 7528786 |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | Potency | = | 31622.8 | nM | 20441198 |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 3548.1 | nM | 23186727 |
NPT776 | Organism | Spodoptera littoralis | Spodoptera littoralis | ED50 | = | 30.5 | nM | 17420206 |
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | 1258.9 | nM | 18663019 | |
NPT1119 | Individual Protein | Arachidonate 12-lipoxygenase | Homo sapiens | Potency | = | 15848.9 | nM | 26090896 |
NPT792 | Individual Protein | Arachidonate 15-lipoxygenase | Homo sapiens | Potency | = | 25118.9 | nM | 26151487 |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | 3162.3 | nM | 21377877 | |
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | = | 3981.1 | nM | 26034885 |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 28183.8 | nM | 26341134 |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 39810.7 | nM | 20361799 |
NPT2 | Others | Unspecified | Activity | = | 20 | % | 19734910 | |
NPT55 | Individual Protein | Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | = | 19905.4 | nM | 23621813 |
NPT197 | Protein-Protein Interaction | Menin/Histone-lysine N-methyltransferase MLL | Homo sapiens | Potency | = | 25118.9 | nM | 21256013 |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | = | 39810.7 | nM | 25946116 |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 6309.6 | nM | 16472241 | |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | Potency | = | 7079.5 | nM | 18077425 |
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | = | 11220.2 | nM | 1825337 |
NPT2 | Others | Unspecified | IC50 | = | 566000 | nM | PubChem BioAssay data set | |
NPT776 | Organism | Spodoptera littoralis | Spodoptera littoralis | Activity | = | 0.45 | ug | DrugMatrix in vitro pharmacology data |
NPT45 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 2 | Homo sapiens | Potency | = | 25118.9 | nM | 21958738 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC181523 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9876 | High Similarity | NPC10576 |
0.9876 | High Similarity | NPC246716 |
0.9814 | High Similarity | NPC26568 |
0.9753 | High Similarity | NPC239440 |
0.9753 | High Similarity | NPC20543 |
0.9753 | High Similarity | NPC1827 |
0.9752 | High Similarity | NPC292788 |
0.9752 | High Similarity | NPC272485 |
0.9695 | High Similarity | NPC139350 |
0.9576 | High Similarity | NPC289147 |
0.9568 | High Similarity | NPC20216 |
0.9565 | High Similarity | NPC156082 |
0.9521 | High Similarity | NPC113446 |
0.9512 | High Similarity | NPC17219 |
0.9506 | High Similarity | NPC112981 |
0.9405 | High Similarity | NPC470091 |
0.9405 | High Similarity | NPC329161 |
0.9405 | High Similarity | NPC240887 |
0.9394 | High Similarity | NPC109827 |
0.9394 | High Similarity | NPC124470 |
0.9379 | High Similarity | NPC143050 |
0.9333 | High Similarity | NPC49487 |
0.9333 | High Similarity | NPC99613 |
0.9325 | High Similarity | NPC300984 |
0.9273 | High Similarity | NPC234331 |
0.9268 | High Similarity | NPC267153 |
0.9264 | High Similarity | NPC93739 |
0.9222 | High Similarity | NPC158226 |
0.9212 | High Similarity | NPC29160 |
0.9207 | High Similarity | NPC474350 |
0.9207 | High Similarity | NPC284007 |
0.9202 | High Similarity | NPC303565 |
0.9152 | High Similarity | NPC8070 |
0.913 | High Similarity | NPC149618 |
0.913 | High Similarity | NPC89625 |
0.913 | High Similarity | NPC471800 |
0.9102 | High Similarity | NPC163130 |
0.9102 | High Similarity | NPC165979 |
0.908 | High Similarity | NPC168616 |
0.908 | High Similarity | NPC83763 |
0.908 | High Similarity | NPC238381 |
0.903 | High Similarity | NPC108767 |
0.8976 | High Similarity | NPC197168 |
0.8976 | High Similarity | NPC234004 |
0.897 | High Similarity | NPC66288 |
0.897 | High Similarity | NPC474187 |
0.8963 | High Similarity | NPC45846 |
0.8957 | High Similarity | NPC54928 |
0.8957 | High Similarity | NPC472456 |
0.8951 | High Similarity | NPC475895 |
0.8944 | High Similarity | NPC133856 |
0.8922 | High Similarity | NPC25361 |
0.8916 | High Similarity | NPC8300 |
0.8909 | High Similarity | NPC47623 |
0.8909 | High Similarity | NPC200594 |
0.8909 | High Similarity | NPC475886 |
0.8909 | High Similarity | NPC474287 |
0.8902 | High Similarity | NPC165977 |
0.8902 | High Similarity | NPC217677 |
0.8889 | High Similarity | NPC273483 |
0.8882 | High Similarity | NPC213382 |
0.8882 | High Similarity | NPC164527 |
0.8862 | High Similarity | NPC236132 |
0.8862 | High Similarity | NPC270837 |
0.8862 | High Similarity | NPC477689 |
0.8855 | High Similarity | NPC474186 |
0.8855 | High Similarity | NPC475883 |
0.8855 | High Similarity | NPC474351 |
0.8841 | High Similarity | NPC146211 |
0.882 | High Similarity | NPC106334 |
0.882 | High Similarity | NPC291049 |
0.882 | High Similarity | NPC233267 |
0.882 | High Similarity | NPC285527 |
0.881 | High Similarity | NPC130920 |
0.881 | High Similarity | NPC85057 |
0.8802 | High Similarity | NPC229632 |
0.8802 | High Similarity | NPC144843 |
0.8802 | High Similarity | NPC294965 |
0.8795 | High Similarity | NPC14353 |
0.8795 | High Similarity | NPC228785 |
0.8795 | High Similarity | NPC56085 |
0.8788 | High Similarity | NPC476981 |
0.8788 | High Similarity | NPC181960 |
0.8786 | High Similarity | NPC207467 |
0.8773 | High Similarity | NPC289968 |
0.8773 | High Similarity | NPC199773 |
0.8771 | High Similarity | NPC214901 |
0.8758 | High Similarity | NPC105415 |
0.8757 | High Similarity | NPC472452 |
0.8757 | High Similarity | NPC37870 |
0.875 | High Similarity | NPC101769 |
0.875 | High Similarity | NPC220313 |
0.875 | High Similarity | NPC7483 |
0.8743 | High Similarity | NPC258331 |
0.8743 | High Similarity | NPC266314 |
0.8743 | High Similarity | NPC311740 |
0.8743 | High Similarity | NPC40491 |
0.8743 | High Similarity | NPC61010 |
0.8743 | High Similarity | NPC278052 |
0.8736 | High Similarity | NPC473785 |
0.8735 | High Similarity | NPC100123 |
0.8721 | High Similarity | NPC233956 |
0.872 | High Similarity | NPC472915 |
0.872 | High Similarity | NPC280937 |
0.872 | High Similarity | NPC186507 |
0.8715 | High Similarity | NPC220369 |
0.8698 | High Similarity | NPC472450 |
0.8698 | High Similarity | NPC275780 |
0.8698 | High Similarity | NPC239752 |
0.8698 | High Similarity | NPC303174 |
0.8698 | High Similarity | NPC326520 |
0.869 | High Similarity | NPC470694 |
0.8683 | High Similarity | NPC299436 |
0.8683 | High Similarity | NPC119224 |
0.8683 | High Similarity | NPC320359 |
0.8683 | High Similarity | NPC292415 |
0.8683 | High Similarity | NPC476980 |
0.8683 | High Similarity | NPC36217 |
0.8683 | High Similarity | NPC84571 |
0.8675 | High Similarity | NPC241904 |
0.8675 | High Similarity | NPC108456 |
0.8675 | High Similarity | NPC44199 |
0.8675 | High Similarity | NPC300727 |
0.8675 | High Similarity | NPC263483 |
0.8675 | High Similarity | NPC36852 |
0.8675 | High Similarity | NPC78225 |
0.8675 | High Similarity | NPC262286 |
0.8671 | High Similarity | NPC245975 |
0.8667 | High Similarity | NPC472909 |
0.8667 | High Similarity | NPC31018 |
0.8667 | High Similarity | NPC38898 |
0.8667 | High Similarity | NPC37392 |
0.8667 | High Similarity | NPC255807 |
0.8663 | High Similarity | NPC475669 |
0.8663 | High Similarity | NPC260263 |
0.8659 | High Similarity | NPC175978 |
0.8655 | High Similarity | NPC476279 |
0.8647 | High Similarity | NPC170245 |
0.8647 | High Similarity | NPC30027 |
0.8647 | High Similarity | NPC272502 |
0.8647 | High Similarity | NPC39091 |
0.8647 | High Similarity | NPC43319 |
0.8642 | High Similarity | NPC5537 |
0.8639 | High Similarity | NPC23298 |
0.8639 | High Similarity | NPC41301 |
0.8639 | High Similarity | NPC152659 |
0.8639 | High Similarity | NPC207690 |
0.8639 | High Similarity | NPC248638 |
0.8639 | High Similarity | NPC236521 |
0.8639 | High Similarity | NPC189473 |
0.8634 | High Similarity | NPC163846 |
0.8634 | High Similarity | NPC225173 |
0.8631 | High Similarity | NPC349525 |
0.8631 | High Similarity | NPC473106 |
0.8631 | High Similarity | NPC32694 |
0.8631 | High Similarity | NPC103201 |
0.8623 | High Similarity | NPC476242 |
0.8623 | High Similarity | NPC477692 |
0.8623 | High Similarity | NPC95936 |
0.8623 | High Similarity | NPC250214 |
0.8623 | High Similarity | NPC85121 |
0.8621 | High Similarity | NPC107244 |
0.8614 | High Similarity | NPC191146 |
0.8614 | High Similarity | NPC474983 |
0.8614 | High Similarity | NPC68093 |
0.8614 | High Similarity | NPC138243 |
0.8614 | High Similarity | NPC142339 |
0.8614 | High Similarity | NPC197751 |
0.8614 | High Similarity | NPC274730 |
0.8614 | High Similarity | NPC472916 |
0.8614 | High Similarity | NPC227062 |
0.8606 | High Similarity | NPC135522 |
0.8606 | High Similarity | NPC477691 |
0.8606 | High Similarity | NPC298802 |
0.8605 | High Similarity | NPC281835 |
0.8605 | High Similarity | NPC241874 |
0.8603 | High Similarity | NPC295436 |
0.8598 | High Similarity | NPC474663 |
0.8598 | High Similarity | NPC208043 |
0.8598 | High Similarity | NPC226973 |
0.8598 | High Similarity | NPC204350 |
0.8598 | High Similarity | NPC198615 |
0.8598 | High Similarity | NPC117579 |
0.8598 | High Similarity | NPC262623 |
0.8598 | High Similarity | NPC149614 |
0.8598 | High Similarity | NPC308451 |
0.8596 | High Similarity | NPC218226 |
0.8596 | High Similarity | NPC477154 |
0.8596 | High Similarity | NPC474024 |
0.8596 | High Similarity | NPC117854 |
0.8596 | High Similarity | NPC247973 |
0.8596 | High Similarity | NPC76647 |
0.8596 | High Similarity | NPC6588 |
0.8588 | High Similarity | NPC50960 |
0.858 | High Similarity | NPC83922 |
0.858 | High Similarity | NPC119660 |
0.858 | High Similarity | NPC25152 |
0.858 | High Similarity | NPC472448 |
0.858 | High Similarity | NPC52204 |
0.858 | High Similarity | NPC265795 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC181523 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8916 | High Similarity | NPD6232 | Discontinued |
0.8876 | High Similarity | NPD5844 | Phase 1 |
0.8757 | High Similarity | NPD7473 | Discontinued |
0.8494 | Intermediate Similarity | NPD7819 | Suspended |
0.8494 | Intermediate Similarity | NPD2801 | Approved |
0.8383 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.8353 | Intermediate Similarity | NPD5494 | Approved |
0.8344 | Intermediate Similarity | NPD2533 | Approved |
0.8344 | Intermediate Similarity | NPD2532 | Approved |
0.8344 | Intermediate Similarity | NPD2534 | Approved |
0.8333 | Intermediate Similarity | NPD3817 | Phase 2 |
0.8323 | Intermediate Similarity | NPD1934 | Approved |
0.8284 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.8284 | Intermediate Similarity | NPD3882 | Suspended |
0.8274 | Intermediate Similarity | NPD1465 | Phase 2 |
0.8253 | Intermediate Similarity | NPD3226 | Approved |
0.8235 | Intermediate Similarity | NPD7075 | Discontinued |
0.8198 | Intermediate Similarity | NPD1247 | Approved |
0.8187 | Intermediate Similarity | NPD919 | Approved |
0.8177 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.8171 | Intermediate Similarity | NPD3818 | Discontinued |
0.8155 | Intermediate Similarity | NPD7411 | Suspended |
0.8146 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.8095 | Intermediate Similarity | NPD6599 | Discontinued |
0.8092 | Intermediate Similarity | NPD6959 | Discontinued |
0.809 | Intermediate Similarity | NPD6559 | Discontinued |
0.8075 | Intermediate Similarity | NPD2935 | Discontinued |
0.8075 | Intermediate Similarity | NPD1551 | Phase 2 |
0.8059 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.8057 | Intermediate Similarity | NPD6166 | Phase 2 |
0.8057 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.8057 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.8012 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.8 | Intermediate Similarity | NPD6801 | Discontinued |
0.7988 | Intermediate Similarity | NPD4380 | Phase 2 |
0.7978 | Intermediate Similarity | NPD7074 | Phase 3 |
0.7975 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7955 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7952 | Intermediate Similarity | NPD1511 | Approved |
0.7952 | Intermediate Similarity | NPD6799 | Approved |
0.7921 | Intermediate Similarity | NPD7054 | Approved |
0.7917 | Intermediate Similarity | NPD920 | Approved |
0.7907 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.7907 | Intermediate Similarity | NPD5402 | Approved |
0.7892 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7877 | Intermediate Similarity | NPD7472 | Approved |
0.7861 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7857 | Intermediate Similarity | NPD1512 | Approved |
0.7833 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7826 | Intermediate Similarity | NPD447 | Suspended |
0.7816 | Intermediate Similarity | NPD3749 | Approved |
0.7816 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.7805 | Intermediate Similarity | NPD2346 | Discontinued |
0.7798 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7798 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7791 | Intermediate Similarity | NPD2799 | Discontinued |
0.7791 | Intermediate Similarity | NPD37 | Approved |
0.7778 | Intermediate Similarity | NPD1607 | Approved |
0.7771 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7771 | Intermediate Similarity | NPD6234 | Discontinued |
0.7771 | Intermediate Similarity | NPD3750 | Approved |
0.7759 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7759 | Intermediate Similarity | NPD4966 | Approved |
0.7759 | Intermediate Similarity | NPD4965 | Approved |
0.7758 | Intermediate Similarity | NPD1549 | Phase 2 |
0.7747 | Intermediate Similarity | NPD7808 | Phase 3 |
0.774 | Intermediate Similarity | NPD5711 | Approved |
0.774 | Intermediate Similarity | NPD5710 | Approved |
0.7735 | Intermediate Similarity | NPD6797 | Phase 2 |
0.7711 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7697 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7697 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.7697 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.7696 | Intermediate Similarity | NPD7501 | Clinical (unspecified phase) |
0.7692 | Intermediate Similarity | NPD7251 | Discontinued |
0.7684 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7683 | Intermediate Similarity | NPD1510 | Phase 2 |
0.7679 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7676 | Intermediate Similarity | NPD8434 | Phase 2 |
0.7654 | Intermediate Similarity | NPD1240 | Approved |
0.7637 | Intermediate Similarity | NPD5953 | Discontinued |
0.7636 | Intermediate Similarity | NPD2796 | Approved |
0.7624 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7622 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7609 | Intermediate Similarity | NPD8312 | Approved |
0.7609 | Intermediate Similarity | NPD8313 | Approved |
0.7607 | Intermediate Similarity | NPD230 | Phase 1 |
0.7602 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.7598 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7576 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.7531 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7527 | Intermediate Similarity | NPD7286 | Phase 2 |
0.75 | Intermediate Similarity | NPD2800 | Approved |
0.75 | Intermediate Similarity | NPD5403 | Approved |
0.75 | Intermediate Similarity | NPD1243 | Approved |
0.7487 | Intermediate Similarity | NPD7782 | Clinical (unspecified phase) |
0.7487 | Intermediate Similarity | NPD7783 | Phase 2 |
0.7487 | Intermediate Similarity | NPD7435 | Discontinued |
0.7487 | Intermediate Similarity | NPD8150 | Discontinued |
0.7485 | Intermediate Similarity | NPD7422 | Clinical (unspecified phase) |
0.7473 | Intermediate Similarity | NPD7228 | Approved |
0.747 | Intermediate Similarity | NPD3748 | Approved |
0.7457 | Intermediate Similarity | NPD1653 | Approved |
0.7456 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7456 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.7439 | Intermediate Similarity | NPD943 | Approved |
0.7427 | Intermediate Similarity | NPD7390 | Discontinued |
0.7423 | Intermediate Similarity | NPD6777 | Approved |
0.7423 | Intermediate Similarity | NPD6779 | Approved |
0.7423 | Intermediate Similarity | NPD6776 | Approved |
0.7423 | Intermediate Similarity | NPD6778 | Approved |
0.7423 | Intermediate Similarity | NPD6781 | Approved |
0.7423 | Intermediate Similarity | NPD6780 | Approved |
0.7423 | Intermediate Similarity | NPD6782 | Approved |
0.7414 | Intermediate Similarity | NPD5808 | Clinical (unspecified phase) |
0.7407 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7403 | Intermediate Similarity | NPD5242 | Approved |
0.7387 | Intermediate Similarity | NPD8151 | Discontinued |
0.7384 | Intermediate Similarity | NPD5401 | Approved |
0.7365 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.7348 | Intermediate Similarity | NPD7229 | Phase 3 |
0.7329 | Intermediate Similarity | NPD1203 | Approved |
0.7326 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7321 | Intermediate Similarity | NPD5408 | Approved |
0.7321 | Intermediate Similarity | NPD5406 | Approved |
0.7321 | Intermediate Similarity | NPD5405 | Approved |
0.7321 | Intermediate Similarity | NPD5404 | Approved |
0.7317 | Intermediate Similarity | NPD2313 | Discontinued |
0.7317 | Intermediate Similarity | NPD1699 | Clinical (unspecified phase) |
0.731 | Intermediate Similarity | NPD7697 | Approved |
0.731 | Intermediate Similarity | NPD7696 | Phase 3 |
0.731 | Intermediate Similarity | NPD7698 | Approved |
0.731 | Intermediate Similarity | NPD6190 | Approved |
0.7293 | Intermediate Similarity | NPD8127 | Discontinued |
0.7289 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7289 | Intermediate Similarity | NPD1933 | Approved |
0.7283 | Intermediate Similarity | NPD3751 | Discontinued |
0.7273 | Intermediate Similarity | NPD7871 | Phase 2 |
0.7273 | Intermediate Similarity | NPD7870 | Phase 2 |
0.7264 | Intermediate Similarity | NPD7875 | Clinical (unspecified phase) |
0.7264 | Intermediate Similarity | NPD7874 | Approved |
0.7239 | Intermediate Similarity | NPD9494 | Approved |
0.7229 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7219 | Intermediate Similarity | NPD6099 | Approved |
0.7219 | Intermediate Similarity | NPD6100 | Approved |
0.7216 | Intermediate Similarity | NPD7458 | Discontinued |
0.7212 | Intermediate Similarity | NPD411 | Approved |
0.7189 | Intermediate Similarity | NPD7177 | Discontinued |
0.7184 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7176 | Intermediate Similarity | NPD2343 | Clinical (unspecified phase) |
0.7176 | Intermediate Similarity | NPD2344 | Approved |
0.7172 | Intermediate Similarity | NPD6823 | Phase 2 |
0.7165 | Intermediate Similarity | NPD6534 | Approved |
0.7165 | Intermediate Similarity | NPD6535 | Approved |
0.7164 | Intermediate Similarity | NPD7701 | Phase 2 |
0.716 | Intermediate Similarity | NPD4308 | Phase 3 |
0.7158 | Intermediate Similarity | NPD3787 | Discontinued |
0.7152 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7152 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7151 | Intermediate Similarity | NPD7003 | Approved |
0.7143 | Intermediate Similarity | NPD6273 | Approved |
0.7143 | Intermediate Similarity | NPD1940 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD9717 | Approved |
0.7143 | Intermediate Similarity | NPD6651 | Approved |
0.7135 | Intermediate Similarity | NPD6386 | Approved |
0.7135 | Intermediate Similarity | NPD6385 | Approved |
0.7128 | Intermediate Similarity | NPD7685 | Pre-registration |
0.7128 | Intermediate Similarity | NPD7240 | Approved |
0.7126 | Intermediate Similarity | NPD1613 | Approved |
0.7126 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7118 | Intermediate Similarity | NPD4476 | Approved |
0.7118 | Intermediate Similarity | NPD4477 | Approved |
0.7118 | Intermediate Similarity | NPD2438 | Suspended |
0.7111 | Intermediate Similarity | NPD5353 | Approved |
0.7108 | Intermediate Similarity | NPD3268 | Approved |
0.7107 | Intermediate Similarity | NPD8285 | Discontinued |
0.7097 | Intermediate Similarity | NPD7893 | Clinical (unspecified phase) |
0.7092 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.7091 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.709 | Intermediate Similarity | NPD7549 | Discontinued |
0.709 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.7059 | Intermediate Similarity | NPD7801 | Approved |
0.7056 | Intermediate Similarity | NPD7700 | Phase 2 |
0.7056 | Intermediate Similarity | NPD7699 | Phase 2 |
0.7055 | Intermediate Similarity | NPD1283 | Approved |
0.7039 | Intermediate Similarity | NPD7615 | Clinical (unspecified phase) |
0.7037 | Intermediate Similarity | NPD7038 | Approved |
0.7037 | Intermediate Similarity | NPD7039 | Approved |
0.7037 | Intermediate Similarity | NPD1608 | Approved |
0.703 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.7024 | Intermediate Similarity | NPD2979 | Phase 3 |
0.7017 | Intermediate Similarity | NPD4288 | Approved |
0.7012 | Intermediate Similarity | NPD2797 | Approved |
0.7011 | Intermediate Similarity | NPD2309 | Approved |
0.7006 | Intermediate Similarity | NPD3764 | Approved |
0.7006 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.6995 | Remote Similarity | NPD5537 | Clinical (unspecified phase) |
0.6977 | Remote Similarity | NPD1471 | Phase 3 |
0.6975 | Remote Similarity | NPD1611 | Approved |
0.6975 | Remote Similarity | NPD422 | Phase 1 |
PubChem CID   | 5317419 |
ChEMBL   | CHEMBL366861 |
ZINC   |
Molecular Weight:   | 472.06 |
ALogP:   | -0.3789 |
MLogP:   | 2.56 |
XLogP:   | 1.971 |
# Rotatable Bonds:   | 13 |
Polar Surface Area:   | 193.96 |
# H-Bond Aceptor:   | 8 |
# H-Bond Donor:   | 4 |
# Rings:   | 3 |
# Heavy Atoms:   | 34 |